{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3174, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "appendix_disclosure", "function": "analyze_data", "notes": "Includes clinical trial data from PERSIST-2 study.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/8", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines a randomized controlled trial design for Myelofibrosis treatment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/9", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "de10bf08-f5e7-4f0d-920a-819aae17d9f8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "PACIFICA, PERSIST-2, and other clinical trial results", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide uses a process flow diagram to represent clinical trial methodology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/10", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "de10bf08-f5e7-4f0d-920a-819aae17d9f8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "PACIFICA, PERSIST-2, and other clinical trial results", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "Includes two charts: a bar chart for SVR achievement and a waterfall plot for median percentage change in spleen volume.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/11", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "de10bf08-f5e7-4f0d-920a-819aae17d9f8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "PACIFICA, PERSIST-2, and other clinical trial results", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 13, "from": 11, "beatId": "3081bf24-4cb4-4efd-b38b-96a57123dff9", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Traction", "beatSlug": null, "evidence": "VONJO's benefits in spleen size reduction, symptom relief, and anemia benefit", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "Includes a bar chart for response rates and a waterfall plot for individual patient symptom changes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/12", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "de10bf08-f5e7-4f0d-920a-819aae17d9f8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "PACIFICA, PERSIST-2, and other clinical trial results", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 13, "from": 11, "beatId": "3081bf24-4cb4-4efd-b38b-96a57123dff9", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Traction", "beatSlug": null, "evidence": "VONJO's benefits in spleen size reduction, symptom relief, and anemia benefit", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "The slide uses three bar charts to illustrate clinical efficacy endpoints related to anemia in a specific patient population.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/13", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "de10bf08-f5e7-4f0d-920a-819aae17d9f8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "PACIFICA, PERSIST-2, and other clinical trial results", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 13, "from": 11, "beatId": "3081bf24-4cb4-4efd-b38b-96a57123dff9", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Traction", "beatSlug": null, "evidence": "VONJO's benefits in spleen size reduction, symptom relief, and anemia benefit", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "Data presented as median values with interquartile ranges (IQR).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/14", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "de10bf08-f5e7-4f0d-920a-819aae17d9f8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "PACIFICA, PERSIST-2, and other clinical trial results", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide presents data from a retrospective analysis of the PERSIST-2 trial.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/15", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a biological process diagram to explain the mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/16", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The slide compares two different clinical trial datasets (PERSIST-2 vs MOMENTUM) to highlight efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/17", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "go_to_market", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/18", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-18", "loopMatches": [ { "to": 20, "from": 18, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "45269494-a660-44f8-8afa-b69eee944753", "evidence": "The VONJO launch strategy and key drivers for success", "position": 2, "objective": "Show the potential for a big win with VONJO", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 18, "beatId": "65f338cb-2a2e-42d7-ba11-1e83ab21dedb", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Go-to-Market", "beatSlug": null, "evidence": "The VONJO launch strategy and key drivers for success", "position": 5, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "Slide emphasizes clinical validation and market positioning via guideline inclusion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/19", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-19", "loopMatches": [ { "to": 20, "from": 18, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "45269494-a660-44f8-8afa-b69eee944753", "evidence": "The VONJO launch strategy and key drivers for success", "position": 2, "objective": "Show the potential for a big win with VONJO", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 18, "beatId": "65f338cb-2a2e-42d7-ba11-1e83ab21dedb", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Go-to-Market", "beatSlug": null, "evidence": "The VONJO launch strategy and key drivers for success", "position": 5, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "go_to_market", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/20", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-20", "loopMatches": [ { "to": 20, "from": 18, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "45269494-a660-44f8-8afa-b69eee944753", "evidence": "The VONJO launch strategy and key drivers for success", "position": 2, "objective": "Show the potential for a big win with VONJO", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 18, "beatId": "65f338cb-2a2e-42d7-ba11-1e83ab21dedb", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Go-to-Market", "beatSlug": null, "evidence": "The VONJO launch strategy and key drivers for success", "position": 5, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a three-column layout to summarize key product benefits.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/21", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide highlights financial stability to support commercialization efforts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/22", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a three-column layout to summarize key business pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/23", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8606-762c-9e2e-06d280bc8199", "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4", "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides", "authorId": "cti-biopharma", "authorName": "CTI BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/24", "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199", "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/thRqspTnFdmipiX-mGzc-Php34GuC0Cq3v3a-xF4Uy4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMDVjYTI5ZjU4ZGNkZDQ0ZDg5NmUyYWNkZjZiYzA4Zi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/1", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "67ad76f2-2dce-4da9-b19f-94c304510500", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The cover and thesis headline grab attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/UW7c_9WX2hSRpNzQQZZwCPf4eXhky-xtmgCfPJqYfCg/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMDVjYTI5ZjU4ZGNkZDQ0ZDg5NmUyYWNkZjZiYzA4Zi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/iZbRniAFpeMtEap3DYndqeHYA2ioGm_Szkw4Gz2j-aE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMDVjYTI5ZjU4ZGNkZDQ0ZDg5NmUyYWNkZjZiYzA4Zi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/Ha_6GcLqYQPZRhqVXZRf97X9xoYoh4tmlUuF90gVYqs/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMDVjYTI5ZjU4ZGNkZDQ0ZDg5NmUyYWNkZjZiYzA4Zi9wMDAxLnBuZw" }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/2", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "67ad76f2-2dce-4da9-b19f-94c304510500", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The cover and thesis headline grab attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "thesis_headline", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/3", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "67ad76f2-2dce-4da9-b19f-94c304510500", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The cover and thesis headline grab attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses a background image of headphones to reinforce the 'music' theme of the strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/4", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "67ad76f2-2dce-4da9-b19f-94c304510500", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The cover and thesis headline grab attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/5", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "67ad76f2-2dce-4da9-b19f-94c304510500", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The cover and thesis headline grab attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "section_divider", "function": "transition", "notes": "The slide features a person holding a smartphone displaying a circular 'flow' interface.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/6", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "9e23d8d6-8f8e-4a76-992a-13d640e8ee5f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "Key highlights and takeaways generate interest.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a hub-and-spoke visual layout with the Deezer logo at the center.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/7", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "9e23d8d6-8f8e-4a76-992a-13d640e8ee5f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "Key highlights and takeaways generate interest.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/8", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "9e23d8d6-8f8e-4a76-992a-13d640e8ee5f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "Key highlights and takeaways generate interest.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/9", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "9e23d8d6-8f8e-4a76-992a-13d640e8ee5f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "Key highlights and takeaways generate interest.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses stacked bar charts to show revenue composition and YoY growth percentages, including FX-adjusted figures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/10", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-10", "loopMatches": [ { "to": 11, "from": 10, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "b59ea0f2-0788-49e9-ba87-98bbcfff1029", "evidence": "The KPI overview slides provide a cascade of information.", "position": 1, "objective": "Explaining revenue growth", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.7, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [ { "to": 13, "from": 10, "beatId": "13d306de-176b-4d2f-b136-2b3dcc3e9650", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "Financial performance data creates desire for more information.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart uses a stacked bar format with annotations for YoY changes and percentage of revenue.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/11", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-11", "loopMatches": [ { "to": 11, "from": 10, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "b59ea0f2-0788-49e9-ba87-98bbcfff1029", "evidence": "The KPI overview slides provide a cascade of information.", "position": 1, "objective": "Explaining revenue growth", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.7, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [ { "to": 13, "from": 10, "beatId": "13d306de-176b-4d2f-b136-2b3dcc3e9650", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "Financial performance data creates desire for more information.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "before_after", "function": "analyze_data", "notes": "The chart uses a standard waterfall bridge to explain the variance in EBITDA between two periods.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/12", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-12", "loopMatches": [ { "to": 13, "from": 12, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "16a57819-b47c-4673-9e6b-08eae1975155", "evidence": "The before-after slide shows the impact of new focus on selected key markets.", "position": 0, "objective": "Highlighting improved adjusted EBITDA", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 13, "from": 10, "beatId": "13d306de-176b-4d2f-b136-2b3dcc3e9650", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "Financial performance data creates desire for more information.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "revenue_buildup", "function": "analyze_data", "notes": "The chart uses a waterfall bridge to explain the movement of cash over a 12-month period.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/13", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-13", "loopMatches": [ { "to": 13, "from": 12, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "16a57819-b47c-4673-9e6b-08eae1975155", "evidence": "The before-after slide shows the impact of new focus on selected key markets.", "position": 0, "objective": "Highlighting improved adjusted EBITDA", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 13, "from": 10, "beatId": "13d306de-176b-4d2f-b136-2b3dcc3e9650", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "Financial performance data creates desire for more information.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "section_divider", "function": "transition", "notes": "Slide number 14, section number 03.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/14", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 14, "beatId": "f0e3d71c-df26-4201-b893-fc97bc05cf7d", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The outlook and next events encourage action.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/15", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 14, "beatId": "f0e3d71c-df26-4201-b893-fc97bc05cf7d", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The outlook and next events encourage action.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "closing_ask", "function": "state_next_steps", "notes": "The slide uses a stylized background image of a building with illuminated windows.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/16", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 14, "beatId": "f0e3d71c-df26-4201-b893-fc97bc05cf7d", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The outlook and next events encourage action.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/17", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a split-bar chart approach to compare metrics across two time periods for two business segments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/18", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "kpi_overview", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/19", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide presents three distinct reconciliation blocks: Gross Profit to Adjusted Gross Profit, Operating Loss to Adjusted EBITDA, and Cash Flow to Free Cash Flow.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/20", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "appendix_data", "function": "analyze_data", "notes": "Financial data presented in K€.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/21", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table displays financial data in thousands of Euros (K€).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/22", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table displays financial figures in K€.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/23", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide presents financial data in K€.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/24", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-86a4-7394-83a9-b57787871eae", "docSlug": "105ca29f58dcdd44d896e2acdf6bc08f", "documentTitle": "Deezer | Results Presentation Deck | 25 slides", "authorId": "deezer", "authorName": "Deezer", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "appendix_data", "function": "analyze_data", "notes": "Part 2 of a 2-part cash flow statement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-86a4-7394-83a9-b57787871eae/25", "deckHref": "/decks/019de073-86a4-7394-83a9-b57787871eae", "deckAnchorHref": "/decks/019de073-86a4-7394-83a9-b57787871eae#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Exhibit 99.1 indicates this is likely a regulatory or investor relations filing.", "imagePath": "https://imgproxy.kitesheet.com/1Z_LkAbycz8idR1tyzl9619NVYq0UC-fO3tLizrOVfU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMjdjMGMzODA0OTdmZTM4MGZjMGVhOTljNjA2ZjFmZS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/1", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/mztAY0iYiCsExQoUR2jcgHMEGZeeK2ZEDTdsiDxlXP4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMjdjMGMzODA0OTdmZTM4MGZjMGVhOTljNjA2ZjFmZS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/h3YX8_pDxvVHdnZ4c8jw10pdF0ff_E7obguHv2pG3UY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMjdjMGMzODA0OTdmZTM4MGZjMGVhOTljNjA2ZjFmZS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/JmU26CUQWGuvF4_Iz0NKhQiqMLe2lTtZ3RfqHIcnMK4/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMjdjMGMzODA0OTdmZTM4MGZjMGVhOTljNjA2ZjFmZS9wMDAxLnBuZw" }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/2", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/3", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/4", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "kpi_overview", "function": "size_opportunity", "notes": "The slide uses a list-based layout to present key metrics with corresponding descriptions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/5", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 5, "beatId": "517c09ce-88cf-479c-a1b1-84d45103534b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "KPI Overview", "beatSlug": null, "evidence": "The presentation provides an overview of Lupus Nephritis in numbers.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "key_messages", "function": "present_framework", "notes": "The slide includes the KDIGO 2012 CKD prognosis matrix.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/6", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "key_messages", "function": "present_framework", "notes": "The slide uses a process-oriented diagram to visualize clinical milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/7", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Data sourced from the Accelerating Medicines Partnership (AMP) Lupus Network.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/8", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 8, "beatId": "b92f5b42-360e-4cda-bacf-17e7366f648f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "The presentation highlights key takeaways from the study.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide uses stacked bar charts to compare response rates (Complete, Partial, No Response) at different time intervals for two drugs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/9", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-9", "loopMatches": [ { "to": 31, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f935949f-a063-4f53-ae76-c20f25bdff22", "evidence": "The presentation implies the cost of inaction through the unmet medical need and limitations of current treatments.", "position": 0, "objective": "What is the cost of not treating Lupus Nephritis effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 9, "beatId": "6f588965-68af-4e25-8791-944847b1aa5f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The presentation identifies the high unmet medical need for Lupus Nephritis treatments.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 10, "from": 9, "beatId": "ac4230da-ff51-45e2-9630-076bd393bf44", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The limitations of current treatments are discussed.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/10", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-10", "loopMatches": [ { "to": 31, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f935949f-a063-4f53-ae76-c20f25bdff22", "evidence": "The presentation implies the cost of inaction through the unmet medical need and limitations of current treatments.", "position": 0, "objective": "What is the cost of not treating Lupus Nephritis effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5a9857ab-edc2-421f-aac9-92c4e50656db", "evidence": "The presentation discusses itolizumab's mechanism of action and efficacy in treating Lupus Nephritis.", "position": 1, "objective": "What are the jobs to be done in treating Lupus Nephritis?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 10, "from": 9, "beatId": "ac4230da-ff51-45e2-9630-076bd393bf44", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The limitations of current treatments are discussed.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" }, { "to": 31, "from": 10, "beatId": "74c9ceff-f718-432a-b48e-9f41e627272b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Itolizumab's potential solution is presented, with efficacy and safety data.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "key_messages", "function": "establish_context", "notes": "Includes scientific citation at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/11", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-11", "loopMatches": [ { "to": 31, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f935949f-a063-4f53-ae76-c20f25bdff22", "evidence": "The presentation implies the cost of inaction through the unmet medical need and limitations of current treatments.", "position": 0, "objective": "What is the cost of not treating Lupus Nephritis effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5a9857ab-edc2-421f-aac9-92c4e50656db", "evidence": "The presentation discusses itolizumab's mechanism of action and efficacy in treating Lupus Nephritis.", "position": 1, "objective": "What are the jobs to be done in treating Lupus Nephritis?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 31, "from": 10, "beatId": "74c9ceff-f718-432a-b48e-9f41e627272b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Itolizumab's potential solution is presented, with efficacy and safety data.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "other", "function": "illustrate_case", "notes": "The slide uses a 'Bench to Bedside' narrative structure to present scientific evidence.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/12", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-12", "loopMatches": [ { "to": 31, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f935949f-a063-4f53-ae76-c20f25bdff22", "evidence": "The presentation implies the cost of inaction through the unmet medical need and limitations of current treatments.", "position": 0, "objective": "What is the cost of not treating Lupus Nephritis effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5a9857ab-edc2-421f-aac9-92c4e50656db", "evidence": "The presentation discusses itolizumab's mechanism of action and efficacy in treating Lupus Nephritis.", "position": 1, "objective": "What are the jobs to be done in treating Lupus Nephritis?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 31, "from": 10, "beatId": "74c9ceff-f718-432a-b48e-9f41e627272b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Itolizumab's potential solution is presented, with efficacy and safety data.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a visual process flow to explain the mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/13", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-13", "loopMatches": [ { "to": 31, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f935949f-a063-4f53-ae76-c20f25bdff22", "evidence": "The presentation implies the cost of inaction through the unmet medical need and limitations of current treatments.", "position": 0, "objective": "What is the cost of not treating Lupus Nephritis effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5a9857ab-edc2-421f-aac9-92c4e50656db", "evidence": "The presentation discusses itolizumab's mechanism of action and efficacy in treating Lupus Nephritis.", "position": 1, "objective": "What are the jobs to be done in treating Lupus Nephritis?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 31, "from": 10, "beatId": "74c9ceff-f718-432a-b48e-9f41e627272b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Itolizumab's potential solution is presented, with efficacy and safety data.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/14", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-14", "loopMatches": [ { "to": 31, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f935949f-a063-4f53-ae76-c20f25bdff22", "evidence": "The presentation implies the cost of inaction through the unmet medical need and limitations of current treatments.", "position": 0, "objective": "What is the cost of not treating Lupus Nephritis effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5a9857ab-edc2-421f-aac9-92c4e50656db", "evidence": "The presentation discusses itolizumab's mechanism of action and efficacy in treating Lupus Nephritis.", "position": 1, "objective": "What are the jobs to be done in treating Lupus Nephritis?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 31, "from": 10, "beatId": "74c9ceff-f718-432a-b48e-9f41e627272b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Itolizumab's potential solution is presented, with efficacy and safety data.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines a clinical trial structure with 5 cohorts ranging from 0.4 to 3.2 mg/kg.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/15", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-15", "loopMatches": [ { "to": 31, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f935949f-a063-4f53-ae76-c20f25bdff22", "evidence": "The presentation implies the cost of inaction through the unmet medical need and limitations of current treatments.", "position": 0, "objective": "What is the cost of not treating Lupus Nephritis effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5a9857ab-edc2-421f-aac9-92c4e50656db", "evidence": "The presentation discusses itolizumab's mechanism of action and efficacy in treating Lupus Nephritis.", "position": 1, "objective": "What are the jobs to be done in treating Lupus Nephritis?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 31, "from": 10, "beatId": "74c9ceff-f718-432a-b48e-9f41e627272b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Itolizumab's potential solution is presented, with efficacy and safety data.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "key_takeaways", "function": "summarize", "notes": "Includes clinical trial abbreviations and source citation in footer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/16", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-16", "loopMatches": [ { "to": 31, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f935949f-a063-4f53-ae76-c20f25bdff22", "evidence": "The presentation implies the cost of inaction through the unmet medical need and limitations of current treatments.", "position": 0, "objective": "What is the cost of not treating Lupus Nephritis effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5a9857ab-edc2-421f-aac9-92c4e50656db", "evidence": "The presentation discusses itolizumab's mechanism of action and efficacy in treating Lupus Nephritis.", "position": 1, "objective": "What are the jobs to be done in treating Lupus Nephritis?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 31, "from": 10, "beatId": "74c9ceff-f718-432a-b48e-9f41e627272b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Itolizumab's potential solution is presented, with efficacy and safety data.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "key_messages", "function": "present_framework", "notes": "The slide appears to be a template or placeholder with only the title present.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/17", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-17", "loopMatches": [ { "to": 31, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f935949f-a063-4f53-ae76-c20f25bdff22", "evidence": "The presentation implies the cost of inaction through the unmet medical need and limitations of current treatments.", "position": 0, "objective": "What is the cost of not treating Lupus Nephritis effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5a9857ab-edc2-421f-aac9-92c4e50656db", "evidence": "The presentation discusses itolizumab's mechanism of action and efficacy in treating Lupus Nephritis.", "position": 1, "objective": "What are the jobs to be done in treating Lupus Nephritis?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 31, "from": 10, "beatId": "74c9ceff-f718-432a-b48e-9f41e627272b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Itolizumab's potential solution is presented, with efficacy and safety data.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "comparison_table", "function": "analyze_data", "notes": "The slide compares clinical trial data for two different drugs using different metrics (fold change vs median % reduction).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/18", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-18", "loopMatches": [ { "to": 31, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f935949f-a063-4f53-ae76-c20f25bdff22", "evidence": "The presentation implies the cost of inaction through the unmet medical need and limitations of current treatments.", "position": 0, "objective": "What is the cost of not treating Lupus Nephritis effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5a9857ab-edc2-421f-aac9-92c4e50656db", "evidence": "The presentation discusses itolizumab's mechanism of action and efficacy in treating Lupus Nephritis.", "position": 1, "objective": "What are the jobs to be done in treating Lupus Nephritis?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 31, "from": 10, "beatId": "74c9ceff-f718-432a-b48e-9f41e627272b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Itolizumab's potential solution is presented, with efficacy and safety data.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }